NCT01824069View on ClinicalTrials.gov

Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

September 30, 2015

Conditions
Nonrevascularizable Critical Ischemia of the Lower Limbs
Interventions
OTHER

Intramuscular injection of a suspension of adult mesenchymal stem cells derived

Intramuscular injection of a suspension of adult mesenchymal stem cells derived from adipose tissue at doses of 1 million per kilo of weight. Only one dosis by patients

Trial Locations (1)

28046

Hospital Universitario La Paz, Madrid

All Listed Sponsors
collaborator

Hospital Universitario La Paz

OTHER

lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT01824069 - Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy | Biotech Hunter | Biotech Hunter